Your browser doesn't support javascript.
loading
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.
Martins, Filipe Correia; Couturier, Dominique-Laurent; Paterson, Anna; Karnezis, Anthony N; Chow, Christine; Nazeran, Tayyebeh M; Odunsi, Adekunle; Gentry-Maharaj, Aleksandra; Vrvilo, Aleksandra; Hein, Alexander; Talhouk, Aline; Osorio, Ana; Hartkopf, Andreas D; Brooks-Wilson, Angela; DeFazio, Anna; Fischer, Anna; Hartmann, Arndt; Hernandez, Brenda Y; McCauley, Bryan M; Karpinskyj, Chloe; de Sousa, Christiani B; Høgdall, Claus; Tiezzi, Daniel G; Herpel, Esther; Taran, Florin Andrei; Modugno, Francesmary; Keeney, Gary; Nelson, Gregg; Steed, Helen; Song, Honglin; Luk, Hugh; Benitez, Javier; Alsop, Jennifer; Koziak, Jennifer M; Lester, Jenny; Rothstein, Joseph H; de Andrade, Jurandyr M; Lundvall, Lene; Paz-Ares, Luis; Robles-Díaz, Luis; Wilkens, Lynne R; Garcia, Maria J; Intermaggio, Maria P; Alcaraz, Marie-Lyne; Brett, Mary A; Beckmann, Matthias W; Jimenez-Linan, Mercedes; Anglesio, Michael; Carney, Michael E; Schneider, Michael.
Afiliação
  • Martins FC; Department of Obstetrics and Gynaecology, University of Cambridge, Cambridge, England.
  • Couturier DL; Experimental Medicine Initiative, University of Cambridge, Cambridge, England.
  • Paterson A; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, England.
  • Karnezis AN; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, England.
  • Chow C; Department of Histopathology, Addenbrookes Hospital, Cambridge, England.
  • Nazeran TM; Department of Pathology and Laboratory Medicine, University of California Davis Medical Center, Sacramento, CA, USA.
  • Odunsi A; OVCARE, Vancouver Coastal Health Research Centre, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
  • Gentry-Maharaj A; Department of Molecular Oncology and Department of Pathology and Laboratory Medicine, BC Cancer Research Centre, BC Cancer, Vancouver, BC, Canada.
  • Vrvilo A; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Hein A; MRC CTU, Institute of Clinical Trials and Methodology, University College London, London, England.
  • Talhouk A; Department of Ob/Gyn, Oregon Health & Science University, Portland, OR, USA.
  • Osorio A; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Hartkopf AD; Department of Molecular Oncology and Department of Pathology and Laboratory Medicine, BC Cancer Research Centre, BC Cancer, Vancouver, BC, Canada.
  • Brooks-Wilson A; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
  • DeFazio A; Department of Molecular Oncology, BC Cancer Research Centre, BC Cancer, Vancouver, BC, Canada.
  • Fischer A; Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Hartmann A; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Hernandez BY; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
  • McCauley BM; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Karpinskyj C; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.
  • de Sousa CB; Department of Gynaecological Oncology, Westmead Hospital, Sydney, NSW, Australia.
  • Høgdall C; Institute of Pathology, Tübingen University Hospital, Tübingen, Germany.
  • Tiezzi DG; Institute of Pathology, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Herpel E; Cancer Center, University of Hawaii, Honolulu, HI, USA.
  • Taran FA; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Modugno F; MRC CTU, Institute of Clinical Trials and Methodology, University College London, London, England.
  • Keeney G; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Nelson G; Department of Gynaecology, Rigshospitalet, University Hospital Copenhagen, Blegdamsvej 9, 2100, København, Denmark.
  • Steed H; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Song H; NCT Tissue Bank, National Center for Tumour Diseases, Heidelberg, Germany.
  • Luk H; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Benitez J; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
  • Alsop J; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Koziak JM; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Lester J; Department of Oncology, Division of Gynecologic Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Rothstein JH; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Royal Alexandra Hospital, Edmonton, AB, Canada.
  • de Andrade JM; Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, England.
  • Lundvall L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Paz-Ares L; Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Robles-Díaz L; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Wilkens LR; Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, England.
  • Garcia MJ; Alberta Health Services-Cancer Care, Calgary, AB, Canada.
  • Intermaggio MP; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Alcaraz ML; Department of Population Health Science and Policy and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Brett MA; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Beckmann MW; Department of Gynaecology, Rigshospitalet, University Hospital Copenhagen, Blegdamsvej 9, 2100, København, Denmark.
  • Jimenez-Linan M; Spanish National Cancer Research Center, CNIO Lung Cancer Clinical Research Unit, New York, NY, USA.
  • Anglesio M; Familial Cancer Unit and Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Carney ME; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Schneider M; Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Br J Cancer ; 123(5): 793-802, 2020 09.
Article em En | MEDLINE | ID: mdl-32555365
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: PTEN Fosfo-Hidrolase Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: PTEN Fosfo-Hidrolase Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido